$CHCI

Comstock Holding Companies, Inc. (CHCI) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.2 3 q226chciinvestorpresenta.htm EX-99.2 q226chciinvestorpresenta Nasdaq: CHCI COMSTOCK HOLDING COMPANIES, INC. | Nasdaq : CHCI Q2 2026 INVESTOR PRESENTATION Exhibit 99.2 Nasdaq: CHCI 2 Disclosures This presentation may include “forward -looking” statements that are made pu

Comstock Holding Companies, Inc. (CHCI) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. chci-20260617 0001299969 FALSE 0001299969 2026-06-17 2026-06-17 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported):

Comstock Holding Companies, Inc. (CHCI) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. chci-20260604 0001299969 FALSE 0001299969 2026-06-04 2026-06-04 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported):

Comstock (NASDAQ: CHCI) reported a significant 38% increase in revenue to $17.4 million for Q1 2026, alongside a 25% rise in net income to $2.0 million. The company's Adjusted EBITDA grew by 6% to $2.2 million, driven by expanding fee-based revenue from property and asset management. Comstock also showcased a debt-free balance sheet, expansion of its managed portfolio to 100 assets with high occupancy rates, and strategic growth into data center and mall management services.

Comstock Holding Companies, Inc. (NASDAQ: CHCI) reported a revenue of $62 million, net income of $17 million, and Adjusted EBITDA of $13 million for FY2025, demonstrating double-digit growth and an expanded portfolio of 92 managed assets. The company's growth was driven by the delivery of The Row at Reston Station, strong leasing rates (over 90%), and the expansion of its ParkX subsidiary, which saw a 76% increase in revenue. Comstock also highlighted its debt-free balance sheet, significant cash reserves, and strategic initiatives in Institutional Venture Platform (IVP) and Data Center Platform (DCP), positioning it for continued growth in 2026 and beyond.

CHCI's Q3 earnings fall year over year due to higher ParkX expansion costs, despite a rise in revenues and continued growth in recurring fee-based income.

CHCI drives growth with recurring fee revenues, rising parking demand, and robust transit-oriented projects, delivering scalable profits with a debt-free balance sheet.

Zacks spotlights Eli Lilly, Oracle, Procter & Gamble, and microcap Comstock Holding, with pharma and staples facing pressure while Oracle and Comstock show momentum.

Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly, Oracle, and Procter & Gamble, as well as a micro-cap stock, Comstock.

CHCI's Q2 EPS improve 56% year over year, while revenues rose 21%, fueled by strong recurring fees, leasing momentum, and progress on its Reston Station development.